Top Brand
Our Recommendation

262+ trust this
WHO GMP Certified
262+ trust this
WHO GMP Certified


WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)
Delivery by
In Blood cancer (Chronic myeloid leukaemia)Blood cancer, also called leukemia, is a cancer of the blood-forming tissues, that decreases the body's ability to fight infection. Knilonat 200mg Tablet kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.
Side effects of Knilonat Tablet The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Knilonat Headache Nausea Abdominal pain Rash Itching Hair loss Muscle pain Fatigue
How to use Knilonat Tablet Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Knilonat 200mg Tablet is to be taken empty stomach.
How Knilonat Tablet works Knilonat 200mg Tablet is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.
Safe: No harmful side effects are associated with consuming alcohol alongside Knilonat 200mg Tablet
Knilonat 200mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Doctor consultation is advised.
Knilonat 200mg Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Knilonat 200mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Knilonat 200mg Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Knilonat 200mg Tablet may not be needed in these patients. Doctor consultation is advised.
Knilonat 200mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Knilonat 200mg Tablet may be needed. Doctor consultation is advised.
If you forget a dose of Knilonat 200mg Tablet , simply continue with your regular schedule and do not take a double dose.
Natco House, Road No.2, Banjara Hills, Hyderabad-500 034, India
Chabner BA, Barnes J, Neal J, et al. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1732-34
Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 953
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 980-82
Medscape. Nilotinib (26 Mar. 2019)
Novartis.com. Nilotinib (26 Mar. 2019)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.